Maxillofacial Plastic and Reconstructive Surgery

Korean Association of Maxillofacial Plastic and Reconstructive Surgeons (대한악안면성형재건외과학회)
권호 표지
DOI QR코드

DOI QR Code

Metastasis via Peritumoral Lymphatic Dilation in Oral Squamous Cell Carcinoma

  • Kim, Han-Seok (Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University) ;
  • Park, Young-Wook (Department of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University)
  • Received : 2014.05.07
  • Accepted : 2014.05.26
  • Published : 2014.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Nodal metastasis is the main prognostic factor in the patients with oral squamous cell carcinoma (OSCC). We investigated the association between tumor-associated lymphatics and OSCC characteristics. Methods: Thirty-four specimens were used for the immunohistochemical staining with the antibody for vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGF receptor (VEGFR)-3, phosphorylated VEGFR-3, D2-40, and matrix metallproteinases (MMPs). We observed the distribution of the lymphangiogenic factors and quantified the degree of expression. We determined lymphatic vessel density (LVD) and lymphatic vessel dilatation with D2-40 immunostaining. We assessed the association of LVD or lymphatic vessel dilatation with tumor progression or tumor differentiation. Results: OSCC cells expressed lymphangiogenic ligands. Lymphangiogenic receptor, VEGFR-3, was expressed and activated in some tumor cells as well as in tumor-associated endothelial cells. LVD was not associated with tumor size or nodal status, but lymphatic vessel dilatation was higher in tumors with nodal metastasis, and also higher in poorly differentiated tumors. In stromal area of OSCC, MMP-1 and MMP-10 were up-regulated and the basement membrane of tumor-associated endothelial cells was destroyed by these collagenases. Conclusion: In the primary tumors with nodal metastasis, especially in poorly differentiated OSCC, tumor cells invaded the dilated lymphatic vessels via ruptured sites. MMP-1 and MMP-10 are important in the lysis of the glycocalyx inside the tumor-associated lymphatic endothelial cells.

Keywords

References

  1. Fronie A, Bunget A, Afrem E, et al. Squamous cell carcinoma of the oral cavity: clinical and pathological aspects. Rom J Morphol Embryol 2013;54:343-8.
  2. Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res 2001;7:462-8.
  3. Achen MG, Stacker SA. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int J Cancer 2006;119:1755-60. https://doi.org/10.1002/ijc.21899
  4. Wigle JT, Harvey N, Detmar M, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002;21:1505-13. https://doi.org/10.1093/emboj/21.7.1505
  5. Jackson DG, Prevo R, Clasper S, Banerji S. LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 2001;22:317-21. https://doi.org/10.1016/S1471-4906(01)01936-6
  6. Wicki A, Christofori G. The potential role of podoplanin in tumour invasion. Br J Cancer 2007;96:1-5. https://doi.org/10.1038/sj.bjc.6603518
  7. Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996;15:290-8.
  8. Witte D, Thomas A, Ali N, Carlson N, Younes M. Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma. Anticancer Res 2002;22:1463-6.
  9. Brychtova S, Bezdekova M, Brychta T, Tichy M. The role of vascular endothelial growth factors and their receptors in malignant melanomas. Neoplasma 2008;55:273-9.
  10. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 1995;92:3566-70. https://doi.org/10.1073/pnas.92.8.3566
  11. O-charoenrat P, Rhys-Evans P, Eccles SA. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis. Cancer 2001;92:556-68. https://doi.org/10.1002/1097-0142(20010801)92:3<556::AID-CNCR1355>3.0.CO;2-Q
  12. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 1990;66:109-13. https://doi.org/10.1002/1097-0142(19900701)66:1<109::AID-CNCR2820660120>3.0.CO;2-A
  13. Miyahara M, Tanuma J, Sugihara K, Semba I. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 2007;110:1287-94. https://doi.org/10.1002/cncr.22900
  14. Park YW, Kim SG, Kim SH, Kim HS, Kim MK. Gene expression for lymphangiogenic factors in oral mucosal squamous cell carcinoma. J Korean Assoc Maxillofac Plast Reconstr Surg 2009;31:453-60.
  15. Zhang Z, Pan J, Li L, Wang Z, Xiao W, Li N. Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue cancer by immunohistochemistry. J Oral Pathol Med 2011;40:127-34. https://doi.org/10.1111/j.1600-0714.2010.00953.x
  16. Tsirlis TD, Papastratis G, Masselou K, et al. Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance? World J Gastroenterol 2008;14:2691-701. https://doi.org/10.3748/wjg.14.2691
  17. Park YW, Kwon KJ, Lee JW. Immunohistochemical study on expression of lymphangiogenic factors in oral cancer. J Korean Assoc Maxillofac Plast Reconstr Surg 2010;32:1-8.
  18. Warburton G, Nikitakis NG, Roberson P, et al. Histopathological and lymphangiogenic parameters in relation to lymph node metastasis in early stage oral squamous cell carcinoma. J Oral Maxillofac Surg 2007;65:475-84. https://doi.org/10.1016/j.joms.2005.12.074
  19. Matsuura M, Onimaru M, Yonemitsu Y, et al. Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells. Am J Pathol 2009;175:1709-21. https://doi.org/10.2353/ajpath.2009.081139
  20. Kitadai Y, Amioka T, Haruma K, et al. Clinicopathological significance of vascular endothelial growth factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J Cancer 2001;93:662-6. https://doi.org/10.1002/ijc.1379
  21. Tang RF, Itakura J, Aikawa T, et al. Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. Pancreas 2001;22:285-92. https://doi.org/10.1097/00006676-200104000-00010
  22. Amioka T, Kitadai Y, Tanaka S, et al. Vascular endothelial growth factor-C expression predicts lymph node metastasis of human gastric carcinomas invading the submucosa. Eur J Cancer 2002;38:1413-9. https://doi.org/10.1016/S0959-8049(02)00106-5
  23. Hadler-Olsen E, Wetting HL, Rikardsen O, et al. Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts. Virchows Arch 2010;457:677-92. https://doi.org/10.1007/s00428-010-0980-y
  24. Funayama A, Cheng J, Maruyama S, et al. Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas. Pathobiology 2011;78:171-80. https://doi.org/10.1159/000324926
  25. Huber GF, Fritzsche FR, Züllig L, et al. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. Int J Cancer 2011;129:1404-9. https://doi.org/10.1002/ijc.25795
  26. Lee SW, Park YW. Expression of endoglin and podoplanin in early and advanced oral squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg 2012;38:145-51. https://doi.org/10.5125/jkaoms.2012.38.3.145
  27. Sedivy R, Beck-Mannagetta J, Haverkampf C, Battistutti W, Honigschnabl S. Expression of vascular endothelial growth factor-C correlates with the lymphatic microvessel density and the nodal status in oral squamous cell cancer. J Oral Pathol Med 2003;32:455-60. https://doi.org/10.1034/j.1600-0714.2003.00168.x
  28. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260-70. https://doi.org/10.1093/jnci/89.17.1260
  29. Kähäri VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 1999;31:34-45. https://doi.org/10.3109/07853899909019260

Cited by

  1. Abnormal Microvasculature in Laryngectomy Mucosal Margins may be Associated with Increased Risk of Fistula pp.1936-0568, 2018, https://doi.org/10.1007/s12105-018-0974-7